{
    "nctId": "NCT04036994",
    "briefTitle": "PBMT for the Management of CIA ( HAIRLASER )",
    "officialTitle": "Photobiomodulation Therapy for the Management of Chemotherapy-induced Alopecia: a Randomized, Placebo-controlled Feasibility Trial",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer, Chemotherapy-induced Alopecia, Alopecia",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 30,
    "primaryOutcomeMeasure": "visual analogue scale (VAS)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Informed Consent as documented by signature.\n* Age 18 years or above\n* Female\n* Use of a wig for at least 2 hours a day\n* Able to read and converse in Dutch\n* Skin type I to IV on the Fitzpatrick Skin Type Scale\n* Diagnosis of non-invasive (stage 0) or invasive (stage 1, 2 and 3A) breast adenocarcinoma.\n* Treatment with neoadjuvant (preoperative) or adjuvant (postoperative) chemotherapy: anthracycline and taxane containing (paclitaxel or docetaxel) chemotherapy regimen.\n* Diagnosed with CIA grade 2 according to Common Terminology Criteria for Adverse Events (CTCAE)\n* Have no documented or observable psychiatric or neurological disorders that might interfere with study participation (e.g., dementia or psychosis).\n\nExclusion Criteria:\n\n* Metastatic disease\n* Severe or unstable cardio- respiratory or musculoskeletal disease\n* Pregnancy\n* Presence of cognitive impairment that might impact study outcomes\n* Previously (before start of chemotherapy) diagnosed with a hair loss condition\n* Receiving scalp cooling during chemotherapy\n* Active infection on the scalp\n* Chronic dermatologic condition (e.g. eczema, psoriasis, infection)\n* Take any of the following medications for 6 months prior to initiation of the study: minoxidil, finasteride (or any other 5\u03b1-reductase inhibitor medications), medications with anti-androgenic properties (e.g. cyproterone, spironolactone, ketoconazole, flutamide and bicalutamide)n medications that can potentially cause hypertrichosis (ciclosporin, diazoxide, phenytoin and psoralens), and oral glucocorticoids",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}